|
Volumn 15, Issue 7, 2009, Pages 718-722
|
Outpacing cancer
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOSINE TRIPHOSPHATE;
BCR ABL PROTEIN;
DASATINIB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ERLOTINIB;
GEFITINIB;
IMATINIB;
NILOTINIB;
PROTEIN TYROSINE KINASE;
CANCER GROWTH;
CANCER INVASION;
CANCER RELAPSE;
CANCER RESEARCH;
CANCER RESISTANCE;
CANCER SUSCEPTIBILITY;
CELL PROLIFERATION;
CHRONIC MYELOID LEUKEMIA;
CLINICAL TRIAL;
DRUG INDUSTRY;
DRUG INHIBITION;
DRUG MARKETING;
FOOD AND DRUG ADMINISTRATION;
GENE MUTATION;
HUMAN;
LUNG CANCER;
LUNG NON SMALL CELL CANCER;
MET GENE;
NONHUMAN;
OXYGEN SUPPLY;
PANCREAS CANCER;
PHYSICIAN;
PRIORITY JOURNAL;
PROTEIN BINDING;
PROTEIN DOMAIN;
REVIEW;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
TUMOR GENE;
CARCINOMA, NON-SMALL-CELL LUNG;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
LUNG NEOPLASMS;
MUTATION;
PIPERAZINES;
PYRIMIDINES;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
EID: 67650482318
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0709-718 Document Type: Review |
Times cited : (2)
|
References (21)
|